BioMarin Pharmaceutical (BMRN) Reports In-Line Q4 Earnings; Guides FY08 Revs
Tweet Send to a Friend
BioMarin Pharmaceutical (Nasdaq: BMRN) reports Q4 EPS of $0.03, 1 cent lower ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
